Boothbay Fund Management’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,352
Closed -$199K 2241
2025
Q3
$199K Buy
+16,352
New +$172K ﹤0.01% 1645
2025
Q1
Sell
-33,131
Closed -$228K 1662
2024
Q4
$228K Buy
33,131
+16,389
+98% +$113K 0.01% 1167
2024
Q3
$123K Buy
+16,742
New +$156K ﹤0.01% 1433
2022
Q2
Sell
-17,284
Closed -$828K 2542
2022
Q1
$828K Buy
17,284
+11,943
+224% +$592K 0.02% 1019
2021
Q4
$271K Sell
5,341
-421
-7% -$18.7K 0.01% 1311
2021
Q3
$233K Buy
+5,762
New +$292K 0.01% 1480
2017
Q1
Sell
-11,303
Closed -$392 895
2016
Q4
$392 Buy
+11,303
New +$633K 0.09% 295
2016
Q1
Sell
-6,498
Closed -$246K 486
2015
Q4
$246K Buy
+6,498
New +$239K 0.11% 339

Other funds holding NUS

Boothbay Fund Management's NUS Position: Q4 2025 in Review

Boothbay Fund Management sold out of Nu Skin (NUS) in Q4 2025, closing a stake of 16,352 shares — an estimated $199K sold.

Boothbay Fund Management first reported a position in NUS in Q4 2015 and held it in 8 quarters. The position peaked at $828K in Q1 2022. 187 funds tracked by Wall St. Rank hold NUS as of Q4 2025.

  • Boothbay Fund Management reported no remaining Nu Skin position as of Q4 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 16,352 Nu Skin shares in Q4 2025, an estimated $199K.
  • Boothbay Fund Management first reported a position in Nu Skin in Q4 2015 and held it in 8 quarters.
  • Boothbay Fund Management's Nu Skin position peaked at $828K in Q1 2022.
  • 187 funds tracked by Wall St. Rank held Nu Skin as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.